Cargando…
In Vitro and In Vivo Pharmacological Characterization of a Novel TRPM8 Inhibitor Chemotype Identified by Small-Scale Preclinical Screening
Transient receptor potential melastatin type 8 (TRPM8) is a target for the treatment of different physio-pathological processes. While TRPM8 antagonists are reported as potential drugs for pain, cancer, and inflammation, to date only a limited number of chemotypes have been investigated and thus a l...
Autores principales: | Iraci, Nunzio, Ostacolo, Carmine, Medina-Peris, Alicia, Ciaglia, Tania, Novoselov, Anton M., Altieri, Andrea, Cabañero, David, Fernandez-Carvajal, Asia, Campiglia, Pietro, Gomez-Monterrey, Isabel, Bertamino, Alessia, Kurkin, Alexander V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877448/ https://www.ncbi.nlm.nih.gov/pubmed/35216186 http://dx.doi.org/10.3390/ijms23042070 |
Ejemplares similares
-
Exploration of
TRPM8 Binding Sites by β-Carboline-Based
Antagonists and Their In Vitro Characterization and In Vivo Analgesic
Activities
por: Bertamino, Alessia, et al.
Publicado: (2020) -
Therapeutic potential of TRPM8 antagonists in prostate cancer
por: Di Donato, Marzia, et al.
Publicado: (2021) -
On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications
por: Ciaglia, Tania, et al.
Publicado: (2023) -
Characterization of New TRPM8 Modulators in Pain Perception
por: De Caro, Carmen, et al.
Publicado: (2019) -
An Efficient Approach to Aromatic Aminomethylation Using Dichloromethane as Methylene Source
por: Ostacolo, Carmine, et al.
Publicado: (2019)